| Reference number |
2025-00298 |
| Coordinator |
NEOGAP Therapeutics AB |
| Funding from Vinnova |
SEK 0 |
| Project duration |
January 2025 - March 2025
|
| Status |
Completed |
| Venture |
Global cooperation 2025 |
Important results from the project
The goal of the project was to expand and maintain relationships with potential investors and ensure continued interest for future investment rounds. During the event, Neogaps VD, Samuel Svensson, gave a 5-minute pitch and participated in several meetings with both investors and bank representatives. Overall, we made many new and important contacts that can facilitate future investments.
Expected long term effects
Overall, we made many new and important contacts that can facilitate future investments.
Approach and implementation
Before our participation in Swiss Nordic Bio, we had an active collaboration with Business Sweden and held dialogues with several investors to present our company. During the event itself, Neogaps VD, Samuel Svensson, gave a 5-minute pitch and participated in several meetings with both investors and bank representatives.
External links
The project description has been provided by the project members themselves and the text has not been looked at by our editors.
